Infected Mushroom

Since selling into the listing day pump (sorry) I've been waiting patiently for $1 MMED.

Daily RSI is now 50+ and showing bullish divergence .

Now that MMED has a new CEO, I have more faith in MMED to deliver useful therapeutics. A more telling bottom signal is the change of CFO ; let's hope Mr. "Greenway" lives up to his name :)
Trade closed: stop reached
Comment: While I believe in the power of psychedelics to assist with mental health issues, I do not expect this company will survive the test of time because they are focusing on LSD which carries massive negative side effects. There's a strong chance MMED with get sued into oblivion for giving test subjects HPPD (Hallucinogen Persisting Perception Disorder). Psychedelic drugs are a double-edged sword.

Furthermore, Kevin O'Leary is a trashcan of a human being and should not be trusted with anything.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.